Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-26 4:00 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Medicxi Growth I LP | 7,464,572 13.000% | 4,980,298 (+200.47%) | View |
| 2023-01-31 4:00 pm Purchase | 13G | Centessa Pharmaceuticals plc CNTA | Medicxi Growth I LP | 19,963,157 21.100% | 1,839,265 (+10.15%) | View |
| 2023-01-31 4:00 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Medicxi Growth I LP | 2,484,274 6.000% | 416,413 (+20.14%) | View |
| 2022-02-08 08:27 am Purchase | 13G | Centessa Pharmaceuticals plc CNTA | Medicxi Growth I LP | 18,123,892 20.160% | 18,123,892 (New Position) | View |
| 2021-11-10 3:21 pm Purchase | 13D | Aura Biosciences Inc. AURA | Medicxi Growth I LP | 3,039,892 10.700% | 3,039,892 (New Position) | View |
| 2021-02-11 10:27 am Unchanged | 13G | OBSEVA SA COM OBSVF | Medicxi Growth I LP | 1,570,000 2.850% | 0 (Unchanged) | View |
| 2021-02-11 08:41 am Unchanged | 13G | MERUS N V COM MRUS | Medicxi Growth I LP | 1,600,000 4.300% | 0 (Unchanged) | View |
| 2020-08-18 4:29 pm Purchase | 13G | Checkmate Pharmaceuticals Inc. CMPI | Medicxi Growth I LP | 1,501,716 7.000% | 1,501,716 (New Position) | View |
| 2020-02-10 12:00 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Medicxi Growth I LP | 2,067,861 8.400% | 2,067,861 (New Position) | View |